1. Home
  2. MBOT vs OCX Comparison

MBOT vs OCX Comparison

Compare MBOT & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • OCX
  • Stock Information
  • Founded
  • MBOT 2010
  • OCX 2009
  • Country
  • MBOT United States
  • OCX United States
  • Employees
  • MBOT N/A
  • OCX N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • MBOT Health Care
  • OCX Health Care
  • Exchange
  • MBOT Nasdaq
  • OCX Nasdaq
  • Market Cap
  • MBOT 32.7M
  • OCX 35.1M
  • IPO Year
  • MBOT N/A
  • OCX N/A
  • Fundamental
  • Price
  • MBOT $1.99
  • OCX $1.96
  • Analyst Decision
  • MBOT Strong Buy
  • OCX Buy
  • Analyst Count
  • MBOT 1
  • OCX 3
  • Target Price
  • MBOT $7.00
  • OCX $4.42
  • AVG Volume (30 Days)
  • MBOT 7.1M
  • OCX 71.5K
  • Earning Date
  • MBOT 11-13-2024
  • OCX 11-12-2024
  • Dividend Yield
  • MBOT N/A
  • OCX N/A
  • EPS Growth
  • MBOT N/A
  • OCX N/A
  • EPS
  • MBOT N/A
  • OCX N/A
  • Revenue
  • MBOT N/A
  • OCX $709,000.00
  • Revenue This Year
  • MBOT N/A
  • OCX N/A
  • Revenue Next Year
  • MBOT N/A
  • OCX $106.34
  • P/E Ratio
  • MBOT N/A
  • OCX N/A
  • Revenue Growth
  • MBOT N/A
  • OCX N/A
  • 52 Week Low
  • MBOT $0.82
  • OCX $1.92
  • 52 Week High
  • MBOT $3.38
  • OCX $3.48
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 59.53
  • OCX 33.88
  • Support Level
  • MBOT $1.59
  • OCX $2.05
  • Resistance Level
  • MBOT $1.91
  • OCX $2.18
  • Average True Range (ATR)
  • MBOT 0.44
  • OCX 0.17
  • MACD
  • MBOT -0.01
  • OCX -0.01
  • Stochastic Oscillator
  • MBOT 39.57
  • OCX 5.60

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.

About OCX Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.

Share on Social Networks: